Ylermi Soini

Ylermi Soini

Auto-generated profile, based on publicly available information

Ylermi Soini

Institute of Clinical Medicine/ Clinical Pathology, University of Eastern Finland, Kuopio, Finland

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2012 in APMIS
Verified
Journal Article
Closed access
PDF file
HMHeta Merikallio
Heta Merikallio
PPPaavo Pääkkö
Paavo Pääkkö
KSKaisa Salmenkivi
Kaisa Salmenkivi
VKVuokko Kinnula
Vuokko Kinnula
THTeihu Harju
Teihu Harju
YSYlermi Soini
Ylermi Soini

16 February 2011 in BMC Cancer
Verified
Journal Article
Open access
PDF file
YSYlermi Soini
Ylermi Soini
HTHanna Tuhkanen
Hanna Tuhkanen
RSReijo K. Sironen
Reijo K. Sironen
IVIsmo Virtanen
Ismo Virtanen
VKVesa Kataja
Vesa Kataja
VKV.-m. Kosma
V.-m. Kosma
Epitheliomesenchymal transition (EMT) is the process where cancer cells attain fibroblastic features and are thus able to invade neighboring tissues. Transcriptional factors zeb1, snai1 and twist regulate EMT.

1 December 2011 in Respiratory Research
Verified
Journal Article
Open access
PDF file
YSYlermi Soini
Ylermi Soini
Tight junctions are the most apically localized part of the epithelial junctional complex. They regulate the permeability and polarity of cell layers and create compartments in cell membranes. Claudins are structural molecules of tight junctions. There are 27 claudins known, and expression of different claudins is responsible for changes in the electrolyte and solute permeability in cells layers. Studies have shown that claudins and tight junctions also protect multicellular organisms from infections and that some infectious agents may use claudins as targets to invade and weaken the host's defense. In neoplastic diseases, claudin expression may be up- or downregulated. Since their expression is associated with specific tumor types or with specific locations of tumors to a certain degree, they can, in a restricted sense, also be used as tumor markers. However, the regulation of claudin expression is complex involving growth factors and integrins, protein kinases, proto-oncogens and transcription factors. In this review, the significance of claudins is discussed in lung disease and development.

15 August 2003
Verified
Journal Article
Closed access
PKPeeter Karihtala
Peeter Karihtala
AMAnne Mäntyniemi
Anne Mäntyniemi
SKSang Won Kang
Sang Won Kang
VKVuokko L Kinnula
Vuokko L Kinnula
YSYlermi Soini
Ylermi Soini

21 June 2011 in BMC Cancer
Verified
Journal Article
Open access
PDF file
PKPeeter Karihtala
Peeter Karihtala
SKSaila Kauppila
Saila Kauppila
YSYlermi Soini
Ylermi Soini
AVArja- Jukkola- Vuorinen
Arja- Jukkola- Vuorinen
Triple-negative breast cancer (TNBC) and basal-like breast cancer (BLBC) are breast cancer subtypes with an especially poor prognosis. 8-Hydroxydeoxyguanosine (8-OHdG) is a widely used marker of oxidative stress and the redox-state-regulating enzymes peroxiredoxins (PRDXs) are efficient at depressing excessive reactive oxygen species. NF-E2-related factor 2 (Nrf2) and Kelch-like ECH-associated protein 1 (Keap1) are redox-sensitive transcription factors that regulate PRDX expression. This is the first study to assess oxidative stress and or cell redox state-regulating enzymes in TNBC and BLBC.

17 May 2010 in Respiratory Research
Verified
Journal Article
Open access
PDF file
RKRiitta Kaarteenaho
Riitta Kaarteenaho
HMHeta Merikallio
Heta Merikallio
SLSiri Lehtonen
Siri Lehtonen
THTerttu Helena Harju
Terttu Helena Harju
YSYlermi Soini
Ylermi Soini
Claudins are the main components of tight junctions, structures which are associated with cell polarity and permeability. The aim of this study was to analyze the expression of claudins 1, 3, 4, 5, and 7 in developing human lung tissues from 12 to 40 weeks of gestation.